Cargando…

P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS

Detalles Bibliográficos
Autores principales: Shortt, Jake, Feldman, Tatyana, Collins, Graham, Zain, Jasmine, Khot, Amit, Seok Kim, Jin, Morschhauser, Franck, Min Kim, Tae, Roderick, Justine, Lim Yoon, Jeong, Sharma, Shringi, Saeh, Jamal, Dai, Jiale, Reyes, Ruben, Olsson, Richardp, Luigi Zinzani, Pier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431056/
http://dx.doi.org/10.1097/01.HS9.0000971460.41693.c0
_version_ 1785091108723752960
author Shortt, Jake
Feldman, Tatyana
Collins, Graham
Zain, Jasmine
Khot, Amit
Seok Kim, Jin
Morschhauser, Franck
Min Kim, Tae
Roderick, Justine
Lim Yoon, Jeong
Sharma, Shringi
Saeh, Jamal
Dai, Jiale
Reyes, Ruben
Olsson, Richardp
Luigi Zinzani, Pier
author_facet Shortt, Jake
Feldman, Tatyana
Collins, Graham
Zain, Jasmine
Khot, Amit
Seok Kim, Jin
Morschhauser, Franck
Min Kim, Tae
Roderick, Justine
Lim Yoon, Jeong
Sharma, Shringi
Saeh, Jamal
Dai, Jiale
Reyes, Ruben
Olsson, Richardp
Luigi Zinzani, Pier
author_sort Shortt, Jake
collection PubMed
description
format Online
Article
Text
id pubmed-10431056
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310562023-08-17 P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS Shortt, Jake Feldman, Tatyana Collins, Graham Zain, Jasmine Khot, Amit Seok Kim, Jin Morschhauser, Franck Min Kim, Tae Roderick, Justine Lim Yoon, Jeong Sharma, Shringi Saeh, Jamal Dai, Jiale Reyes, Ruben Olsson, Richardp Luigi Zinzani, Pier Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431056/ http://dx.doi.org/10.1097/01.HS9.0000971460.41693.c0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Shortt, Jake
Feldman, Tatyana
Collins, Graham
Zain, Jasmine
Khot, Amit
Seok Kim, Jin
Morschhauser, Franck
Min Kim, Tae
Roderick, Justine
Lim Yoon, Jeong
Sharma, Shringi
Saeh, Jamal
Dai, Jiale
Reyes, Ruben
Olsson, Richardp
Luigi Zinzani, Pier
P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
title P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
title_full P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
title_fullStr P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
title_full_unstemmed P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
title_short P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
title_sort p1141: encouraging complete responses (crs) observed with cdk9 inhibitor azd4573 in patients (pts) with relapsed/refractory (r/r) peripheral t-cell lymphoma (ptcl): early trial analysis
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431056/
http://dx.doi.org/10.1097/01.HS9.0000971460.41693.c0
work_keys_str_mv AT shorttjake p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT feldmantatyana p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT collinsgraham p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT zainjasmine p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT khotamit p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT seokkimjin p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT morschhauserfranck p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT minkimtae p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT roderickjustine p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT limyoonjeong p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT sharmashringi p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT saehjamal p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT daijiale p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT reyesruben p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT olssonrichardp p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis
AT luigizinzanipier p1141encouragingcompleteresponsescrsobservedwithcdk9inhibitorazd4573inpatientsptswithrelapsedrefractoryrrperipheraltcelllymphomaptclearlytrialanalysis